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Abstract 
The development of environmentally benign reactions is an important goal in synthetic 
organic chemistry and chemical engineering. However, catalytic enantioselective oxidations 
using transition-metal complexes are limited when the oxidant is hydrogen peroxide. The two 
main difficulties of using hydrogen peroxide in the presence of transition metal complexes are 
the homolytic cleavage generating OH radicals and the catalase reaction with formation of 
dioxygen. The current applications of asymmetric sulfoxidation, epoxidation, dihydroxylation 
of alkenes and hydroxylation will be herein reported. Use of non-heme systems will be 
presented. The possibility of asymmetric oxidation catalyzed by metalloporphyrins will also 
be discussed. 
Keywords: Hydrogen peroxide; Metal complex; Asymmetric sulfoxidation; Asymmetric 
epoxidation; Asymmetric dihydroxylation; Metalloporphyrin 
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1. Introduction  
 Oxidation catalysis is an important domain of chemical research. Numerous 
applications are nowadays in the fine chemical industry. The nature of the terminal oxidant is 
often crucial for the efficiency of oxidation reactions, and typical oxygen-transfer reagents 
include alkyl hydroperoxides, iodosylbenzene, peroxycarboxylic acids, hypochlorite, 
dioxygen and oxone. Despite significant efforts to utilize H2O2 in asymmetric oxidation 
catalysis, only a few general systems work well with this abundant, environmentally benign, 
atom-economical and relatively safe oxidant [1,2]. However hydrogen peroxide is probably 
the best terminal oxidant after dioxygen with respect to environmental and economic 
consideration [1,3]. It is also very attractive because its solubility in water and many organic 
solvents is quite large. As a result, oxidation systems that use hydrogen peroxide in 
conjunction with catalytic amount of cheap, relatively non-toxic metals such as iron, and to a 
less extent manganese, are highly desired for application in pharmaceutical area. Despite 
significant efforts to utilize H2O2 in asymmetric oxidation catalysis, only a few general 
systems are efficient with this environmentally benign oxidant [2]. The only side-product 
when using hydrogen peroxide as oxidant is a water molecule. However, the two main 
difficulties of using hydrogen peroxide in the presence of transition metal complexes are the 
homolytic cleavage generating OH radicals and the catalase reaction with formation of 
dioxygen [4].  
Recently, however, there is a revival in developing original and efficient system in 
asymmetric catalysis [5]. Thus we have now the development of new generations of metal 
complexes which are able to selectively catalyze various oxidation reactions. In this review 
the focus is on promising asymmetric oxidation systems using hydrogen peroxide as oxidant 
and metal-based catalysts. Organic catalysts designed for asymmetric oxidation may also 
operate with hydrogen peroxide [2, 6-8] but they are beyond the scope of this review. Direct 
use of hydrogen peroxide as primary oxidant, in the Baeyer-Villiger oxidation has also been 
reported [9]. However, only a few catalysts are used in combination with hydrogen peroxide 
as the oxidant for enantioselective reactions [10-12]. Consequently, this reaction will not be 
developed in the present review, there are excellent reviews on this topic [9, 13, 14]. 
2. Asymmetric sulfoxidation 
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The selective oxidation of sulfides to sulfoxides has attracted much attention over the 
years after the pioneering work of Kagan [15] and Modena [16]. Hydrogen peroxide, 
however, has to be used in a controlled manner, due to the possibility of an over-oxidation 
reaction since possible formation of sulfones is also observed in various reactions as by-
products[17]. This formation may suggest the existence of a kinetic resolution process during 
the course of the reaction. To investigate this aspect, the time dependence of the asymmetric 
process should be studied in more details. Sulfoxides also constitute chiral synthons in 
organic synthesis for the preparation of biologically active compounds [18]. They also serve 
as chiral auxiliaries [19]. There are recent and excellent reviews on this topic [17,18,20-23]. 
 
2.1. Iron systems 
 
Among all methods described so far [17], the asymmetric oxidation of sulfides by 
metal catalysts is one of the most attractive routes to optically active sulfoxides, and quite 
recently, even nontoxic and inexpensive iron complexes have been developed successfully, 
using hydrogen peroxide as oxidant [24-26]. Recent results will be separated in two parts: 
non-heme systems and iron porphyrin catalysts. 
 
2.1.1 Non-heme systems 
 
The iron complex [FeO(pb)4(H2O)2]ClO4 (pb = (-)-4,5-pinene-2,2’-bipyridine) was 
reported  in 1999 by Fontecave and coworkers [27, 28] as catalyst for the sulfide oxidation 
with hydrogen peroxide with yields ranging from 45 to 90%, but the enantioselectivity was 
only modest (ee = 40%) (Scheme 1). The catalytic properties of the mononuclear complex 
were compared to those of its related dinuclear analogue. Each system generates specific 
peroxo adducts but the latter was found more reactive and enantioselective than its 
mononuclear counterpart [29].   
 Since then several examples of asymmetric oxidation of sulfides using H2O2 catalyzed 
by non-heme chiral iron complexes have been reported by Bolm and co-workers (Scheme 2) 
[18, 24, 25, 30]. Despite the remarkable application of the chiral iron complexes with H2O2, 
the rather low reaction yields and the moderate enantioselectivities remained problematic. 
These limitations, however, could be overcome by the use of additives such as benzoic acid 
derivatives or their lithium salts [24]. After a comprehensive screening of carboxylic acids, p-
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methoxybenzoic acid or the corresponding lithium carboxylate was found to be the most 
efficient additive in this transformation. The use of this additive dramatically improved the 
reaction yields as well as the enantioselectivities [25]. An iron-catalyzed asymmetric sulfide 
oxidation was also found to be the key step in the synthesis of the non-steroidal anti-
inflammatory drug Sulindac (Figure 1) [31]. Both enantiomers of the chiral product can be 
prepared with 92% ee in good yield. 
Applicable asymmetric oxidation of sulfides using a Fe(salan) complex/aqueous 
hydrogen peroxide system was also reported in water by Egami and Katsuki [26]. 
Remarkably, the reactions were carried out in water using a chiral iron catalyst without a 
surfactant and higher enantioselectivity was observed in water than in methanol. After 
optimization, the reaction proceeds with high enantioselectivity (87-94% ee)(Scheme 3) [32]. 
The enantioselective oxidation of thioanisole to methyl phenyl sulfoxide has been 
recently realized by using new iron(III) complexes, generated in situ from primary amine-
derived non-symmetrical Schiff base ligands (Figure 2) and aqueous H2O2 as environmentally 
benign oxidant [33].Moderate yields (up to 69%) and reasonable enantiomeric excesses (up 
to 54% ee) could be achieved when the reaction was carried out in THF and progressive 
addition of H2O2 using a syringe pump within 5 or 7 h. 
2.1.2 Iron porphyrins 
Metalloporphyrins, widely studied as models of hemes or cytochrome P-450 [34], 
have been known to exhibit the catalytic activity for monooxygenation, proceeding via the 
formation of high valency metal-oxygen complex intermediates. However the asymmetric 
oxidation of sulfides catalyzed by chiral iron porphyrin was still unprecedented until 2011 
when the oxidant is hydrogen peroxide. This is quite surprising since the first 
metalloporphyrin-catalyzed oxygenation with hydrogen peroxide reported the formation of 
sulfoxide from sulfide [35]. However, it should be noted that the enzymatic oxidation of 
sulfides to optically active sulfoxides catalyzed by peroxidases [36-39] and other heme 
proteins [19, 40] was previously reported. Vanadium-based semi-synthetic enzymes catalyzed 
the enantioselective oxidation of prochiral sulfides with H2O2 affording the S-sulfoxide, e.g. 
in 66% ee, at quantitative conversion of thioanisole [41]. 
There are previously reported asymmetric homogeneous iron-porphyrin-catalyzed 
sulfide oxidations in the literature with iodosylbenzene as oxidant [42-47].  Many iron 
porphyrin-H2O2 systems have been studied to get information on the mechanism and nature of 
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the active intermediates [4, 48-50]. The two main obstacles when using hydrogen peroxide are 
the high activity of many first-row transition metals in its decomposition thereof, the so-called 
catalase reaction [5] and the catalyst destruction by hydroxyl radicals readily released by 
homolytic H2O2 decomposition. However, the first enantioselective iron-porphyrin-catalyzed 
sulfoxidation (ee up to 90%) with aqueous hydrogen peroxide was recently reported by 
Simonneaux group [51]. The reactions were carried out in methanol and water using chiral 
water-soluble iron porphyrins as catalysts (Figure 3). This investigation of H2O2 asymmetric 
oxidation of sulfides in a protic solvent shows the practicability of the process (absence of 
excess of oxidant and substrate, small reaction time and room temperature reaction) even 
though the chiral catalyst does not bear a robust porphyrin ligand. A protection of the 
oxoiron(IV) cation radical intermediate from the two norbornane groups fused to the central 
benzene ring is suggested since a similar reaction catalyzed by FeClTPPS (tetra-p-
sulfonatophenylporphyrin iron chloride) yields to the destruction of the porphyrin ring[52]. 
 2.2 Ruthenium catalysts  
With the exception of a few specific systems [53], the combination of ruthenium 
catalysts with hydrogen peroxide has not been well developed owing to rapid decomposition 
of hydrogen peroxide [54]. However, for the first time the potential of the “chiral-at-metal” 
cis-[Ru(dmp)2-(CH3CN)2]2+ complex (Figure 4), with achiral phenanthroline ligands, in pure 
enantiomeric form, as a catalyst for enantioselective sulfoxidation by hydrogen peroxide was 
reported by Fontecave and co-workers [55]. Even though the enantiomeric excesses are small 
(< 20%), this work also provides the first experimental demonstration that the chiral 
information carried by a stereogenic metal center can be catalytically transferred to molecules 
during stereoselective oxidation [55]. 
2.3 Manganese systems 
2.3.1  Non-porphyrinic manganese systems 
 
Jacobsen was first to successfully use chiral salen manganese catalysts (Figure 5) in 
asymmetric sulfide oxidation using complexes that also exhibited highly selective asymmetric 
epoxidation [56]. Modest enantioselectivity was observed with 34-68% ee using unbuffered 
hydrogen peroxide as the stoichiometric oxidant and acetonitrile as solvent. 
More recently, several manganese complexes prepared from an easy accessible 
diimine ligand (Scheme 4) proved to be catalysts for asymmetric sulfoxidation by hydrogen 
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peroxide. Enantiomeric excesses ranging from 5% to 62% were obtained with a variety of 
alkyl sulfides [57]. 
In situ prepared manganese complexes with chiral amino alcohols as ligands have also 
been used in the catalytic oxidation of sulfides to sulfoxides using hydrogen peroxide at 0°C 
in acetone. Methyl  phenyl sulfoxide was obtained in 55% yield and turnover numbers up to 
250, while the formation of sulfone is almost suppressed but with low enantiomeric excess 
(<20%) [58]. 
Very recently, a chiral sulfonato-(salen)Mn(III) complex was grafted onto a flexible 
polysiloxane, then axially coordinated by 3-aminopropyl functionalized silica gel, and 
eventually dispersed into imidazolium ionic liquid BMImX (BMIm+ = 1-n-butyl-3-
methylimidazolium; X− = BF4−), which produced a new triply immobilized (salen)Mn(III) 
catalyst for asymmetric sulfoxidation reactions [59]. In general, these reactions proceeded 
smoothly (TOF values >10) and exhibited eevalues up to 92%.  
It has also been reported the incorporation of an achiral Mn(salen) into apo-Mb using a 
dual covalent anchoring approach [60]. The resulting artificial enzyme displays higher 
enantioselectivity than those constructed using either a noncovalent or single covalent 
anchoring approach [61,62]. 
 
2.3.2 Manganese porphyrins 
The investigation of hydrogen peroxide oxidation of sulfides in a protic solvent shows that 
catalysis by Mn(III)tetraarylporphyrins can provide an interesting route to the transformation 
of mustard and related sulfides into sulfoxides and sulfones [63]. However, until very recently 
[64], the asymmetric oxidation of sulfides catalyzed by chiral manganese porphyrin is still 
unprecedented when the oxidant is H2O2 although there is one example of sulfoxidation with 
chiral manganese corroles[65]. The enantioselective synthesis of the pharmacology important 
R-modafinil (Figure 1), in 88% yield and 73% ee was reported as an application of the corrole 
manganese catalyst. An efficient asymmetric oxidation of sulfides catalyzed by water-soluble 
chiral manganese porphyrin (Figure 3) was also carried out in presence of cheap and 
environmentally benign oxidant H2O2 at 25°C [64]. Prochiral sulfides were converted to 
sulfoxides with up to 100% conversion and up to 57% enantiomeric excess. The study 
demonstrated the necessity of water as solvent and imidazole as co-catalyst. Application to 
the preparation of the optically active drug, sulindac (Figure 1), was also demonstrated [64].  
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Albumin-conjugated corrole [65,66] and porphyrin [67] manganese complexes have also 
been found useful for asymmetric oxidation of sulfides.  Using hydrogen peroxide as oxidant, 
sulfoxides were obtained in up to 74% ee [66]. 
2.4 Vanadium catalysts 
 
There are two reviews on vanadium-catalyzed asymmetric oxidation reported by Bolm 
in 2003[68] and Volcho in 2009 [69]. A vanadium(IV)-Schiff base complex  (Figure 6) was 
successfully applied for the first time in 1995 for the oxidation of thioanisole to the 
corresponding sulfoxide by the use of hydrogen peroxide with good enantioselectivity (ee up 
to 85%) [70]. The reaction was found remarkable since the oxidation can be performed in 
open reaction vessels (atmospheric oxygen and water do not affect the outcome) and only 
0.01 mol% of the catalyst was necessary. Similar ligands were modified by introducing a 
second element of chirality in the salicylic aldehyde moiety to give enantiomeric excesses up 
to 78% ee for the sulfoxidation of thioanisole [71]. Schiff base ligands possessing various 
1,1’-binaphtyl units were also tested as efficient chiral auxiliaries in the presence of vanadium 
complex [72]. High enantioselectivity (up to 93% ee) was observed with acceptable chemical 
yield. Two librairies of chiral Schiff base ligands were synthesized by Anson and coworkers 
[73] for the optimization of Bolm’s protocol [70]. Some of the vanadium complexes were 
found highly enantioselective and optically active sulfoxides were obtained in good yields 
with up to 97% ee. Other recent investigations on this Bolm catalytic system have mainly 
focused on structural modification of chiral Schiff bases [74-78], using of chlorine dioxide as 
oxidant [79] or portionwise addition of H2O2 [80]. Sulfoxidation and concomitant efficient 
kinetic resolution of sulfoxides was also reported with vanadium-salan system [81] and 
vanadium-Schiff base complexes [82, 83]. 
  The first example of the catalytic asymmetric oxidation of tert-butyl disulfide giving 
tert-butyl tert-butanethiosulfinate (Scheme 5) obtained with 91% enantiomeric excess in 
yields of 92 % was described by Ellman and co-workers [84, 85]. The application of H2O2 as 
stoichiometric oxidant in the presence of 0.25 mol % of VO(acac)2 and 0.26 mol % of a chiral 
Schiff base ligand was found both convenient and cost-effective. A facile and selective 
method for the bis(arylthio)alkanes into C2 symmetric chiral sulfoxide transformation was 
also described by Skarzewski and co-workers [86]. The two-phase oxidation of bis-sulfides 
with hydrogen peroxide catalyzed by vanadium complex of chiral Schiff base leads to the 
A

corresponding chiral mono- and bis-sulfoxides. In the case of 1,2-bis(arylthio)ethanes the 
respective optically active bis-sulfoxides are formed in up to over 95% ee [86]. 
  Despite extensive studies on the catalytic system first reported by Bolm in 1995 [70], 
only few papers [87-89] report crystal structures of oxovanadium(V) complexes of Schiff 
bases of chiral amino alcohols. However, recently, the first example on crystal and molecular 
structure of oxido-bridged dinuclear vanadium(V) complex incorporating tridentate Schiff 
base ligand derived from chiral amino alcohol was reported by Romanovski and Lys [90]. 
 
2.5  Niobium catalysts 
Miyazaki and Katsuki reported the first asymmetric sulfoxidation with urea-hydrogen 
peroxide catalyzed by niobium [91]. Using niobium(salen) complex, the oxidation of aryl 
alkyl sulfides and benzyl methyl sulfide showed good enantioselectivity under optimized 
conditions (ee up to 86%). Possible oxidation of niobium(III) to niobium(V) during complex 
formation was suggested based on mass spectrometry analysis. 
  2.6 Titanium catalysts 
Asymmetric oxidation of sulfides catalyzed by titanium complexes in the synthesis of 
biologically active sulfoxides has been reported as a review in 2009 [69] and also, as chapter 
in reviews [20, 22].  Since the pioneering works of Kagan [15] and Modena [16] who 
described enantioselective sulfoxidation with alkyl hydroperoxides using titanium tartrate 
catalysts, a wide variety of other chiral titanium complexes has been applied in this reaction, 
some of the catalytic systems using hydrogen peroxide as oxidant. In 2001, Katsuki and co-
workers [92, 93] developed a highly enantioselective oxidation of sulfides using Ti(salen) 
complex as catalyst and urea-hydrogen peroxide as the oxidant. Asymmetric oxidation of 2-
substituted 1,3-dithianes using a Ti(salen) and urea-hydrogen peroxide system in methanol 
was found to proceed with high enantioselectivity to give the corresponding mono-sulfoxides 
[94,95]. In these system, a di-µ-oxo Ti(salen) complex, prepared by treatment of Ti(salen)Cl2 
with water and triethylamine, was used as the catalyst (Scheme 6). 
Sulfoxidation catalysts generated in situ from titanium(IV) isopropoxide and enantiopure 
Schiff bases promote the enantioselective oxidation of alkyl aryl sulfides to the corresponding 
sulfoxides at low catalyst loading (<1 mol%), 30% aqueous hydrogen peroxide being the 
terminal oxidant [96]. Upon screening of several ligands derived from aminoalcohols and 
B

salicylaldehydes, a catalyst affording sulfoxides with over 90% chemoselectivity and up to 
60% ee was found, and the kinetic of the catalytic reaction was analyzed by 1H NMR. 
Asymmetric oxidation of sulfides to sulfoxides by aqueous hydrogen peroxide with 
catalysis by titanium-salan complexes was reported by Bryliakov and Talsi [97]. Optically 
active sulfoxides have been obtained with good to high enantioselectivities (up to 97% ee) by 
a tandem enantioselective oxidation and kinetic resolution procedure, the catalyst performing 
over 500 turnovers with no loss of enantioselectivity. 
For eventual in situ preparation of chiral (R)-menthyloxycarbonyl-1,2-dihydroisoquinolin-
1-yl) hydroperoxides and their application in stereoselective O-transfer reactions, 
isoquinolines were combined with (R)-menthyl chloroformate, hydrogen peroxide and metal 
alkoxides [98]. These mixtures allowed a stereoselective synthesis of aryl methyl sulfoxides 
from corresponding sulfides. The stereoselectivity results from a kinetic resolution of racemic 
sulfoxides formed in the first step wherein the (S)-enantiomer was faster oxidized to the 
corresponding sulfone [98]. However, only low enantioselectivities were achieved with this 
system (ee up to 23%) with a large amount of sulfone (19%). 
Bryliakov and Talsi reported a simple and efficient catalytic procedure for the oxidation of 
bulky thioethers with hydrogen peroxide [99,100]. This has been achieved by reducing the 
steric bulk of the salicylidene rings [100]. 
Asymmetric sulfoxidation of thioanisole by helical Ti(IV) salan catalysts has been 
recently developed [101]. Complexation of these flexible ligands to TiCl4 produced 
TiCl2(salan) complexes which were tested for the asymmetric sulfoxidation of thioanisole 
with hydrogen peroxide as oxidant (ee up to 43%). New Ti-salan complexes were also applied 
as catalysts in the sulfoxidation of thioanisole with H2O2 in dichloroethane [102]. They 
showed high activities but only moderate enantioselectivities (ee up to 51%). For greener 
catalysis purpose, these complexes were also tested in selected ionic liquids with hydrogen 
peroxide as oxidant but with reduced induced asymmetry (ee up to 18%). 
Very recently, an efficient asymmetric oxidation of prochiral sulfides catalyzed by a series 
of simple in situ generated complexes based on chiral amino alcohol derived Schiff bases with 
Ti(Oi-Pr)4 was carried out in presence of H2O2 at 0°C [103]. Prochiral sulfides were 
converted to respective chiral sulfoxides efficiently (93% conversion, up to 98% ee) with this 
system.  
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  2.7  Platinum catalysts 
 Stereoselective sulfoxidation of prochiral aryl alkyl sulfides to the corresponding 
sulfoxides can be achieved in water-surfactant medium with hydrogen peroxide catalyzed by 
chiral platinum diphosphine complex (Figure 7) with ee up to 88% [104]. A remarkable key 
feature was the easy isolation of the products by simple diethyl ether/water-surfactant two-
phase separation.  
  2.8  Copper catalysts  
Copper has received some attention in metal-catalyzed asymmetric oxidation, using 
hydrogen peroxide as oxidant [75,105] but with moderate ee and low yields. More recently, 
copper Schiff base mediated asymmetric oxidation of aryl benzyl sulfides has been reported 
by Maguire et al. [106]. These results compare favourably to other known copper mediated 
asymmetric sulfide oxidation methods, especially in term of enantiocontrol (up to 81% ee), 
but yields and overall enantioselectivities are modest compared to other available methods. 
The method is similar to the vanadium and iron Schiff base mediated oxidations reported by 
Bolm in that the same oxidant and ligands are employed. Expansion of this investigation 
resulted in improved yields, while retaining good enantioselectivity through variation of 
reaction conditions, such as the nature of the solvent and small change in ligand structure 
[107]. 
2.9  Aluminum catalysts 
Katsuki and co-workers [108] first discovered that treatment of Al(salalen) complexes 
with water provided new-water compatible complexes which can be used as catalysts under 
aqueous conditions for asymmetric sulfoxidation reactions. Later, the same group [109, 110] 
has reported that aluminum-(salalen) complex (Figure 8) is an effective catalyst for 
asymmetric oxidation of sulfur compounds such as acyclic and cyclic sulfides in the presence 
of aqueous hydrogen peroxide as the stoichiometric oxidant. This work has been extended to 
asymmetric oxidation of cyclic dithioacetals with high diastereo- and enantioselectivity [111]. 
 
2.10 Tungsten catalysts 
 
The use of heterogeneous catalysts under ambient conditions offers several advantages 
compared with their homogeneous counterparts e.g. ease of recovery and recycling and 
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enhanced stability. New heterogeneous catalysts with tungsten-based system have been 
reported using hydrogen peroxide as oxidant. Thus WO3-catalyzed asymmetric oxidation of 
thioethers and kinetic resolution of sulfoxides with 30% aq. H2O2 in the presence of cinchona 
alkaloids under heterogeneous conditions affords chiral sulfoxides in high yields with 
moderate to good enantioselectivities (ee up to 90%) [112]. The asymmetric oxidation of 
sulfides catalyzed by WO3 and H2O2 in the presence of salan as chiral ligands under 
heterogeneous conditions has been also reported but with moderate enantioselectivities (ee 
max: 67%) [113]. The synthesis and characterization of new chiral polyoxo-
tungstophosphonates, in enantiopure form, derived from the covalent functionalization of 
lacunary Keggin-type precursors has been more recently reported [114]. The resulting 
complexes display high hydrolytic stability but, unfortunately, very low enantioselectivity (ee 
< 10%) as catalysts in sulfoxidation reactions, in combination with hydrogen peroxide as bulk 
oxidant. Although these preliminary catalytic results are of limited synthetic interest, the 
oxidative activity and stability of these tungsten-based systems offer a starting point for the 
development of novel stereoselective heterogeneous catalysts. 
A summary of selected asymmetric sulfoxidations so far showing the best 
enantioselectivity is given in the Table 1. Thus, several catalytic systems based on vanadium 
(Bolm), iron (Bolm, Katsuki, Simonneaux), aluminium (Katsuki), titanium (Bryliakov) which 
have been discovered within the last 15 years, employ H2O2, affording sulfoxides with high 
selectivities and with ee up to 98 %, performing large turnovers and demonstrating good 
oxidant economies. It is also noteworthy that a number of important chiral sulfoxides and 
biologically active compounds are already prepared by the use of metal catalysts with high 
yield and enantioselectivity. However, there are still many challenging areas for future 
research. First, new systems are necessary for oxidation of molecules containing highly 
reactive groups such as carbonyl, hydroxyl and unsaturated groups. There is also a great need 
for discovering alternative systems which are less destructive to the chiral ligands.Design and 
synthesis of simpler porphyrin and non-porphyrin chiral ligands are still an urging need.
 
3. Asymmetric epoxidation of alkenes 
 
Catalytic asymmetric epoxidation reactions play a major role in organic chemistry since 
the optically active epoxides are important building blocks [1, 115, 116]. In particular, 
catalytic asymmetric reactions in aqueous solutions are attractive, but rare [7]. Therefore until 
2006, results obtained in the asymmetric epoxidation with H2O2 and chiral metal catalysts 
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have been rather disappointing [5]. It is only quite recently, however, that the metal-catalyzed 
asymmetric epoxidation of aromatic alkenes with hydrogen peroxide as the oxygen source 
and various chiral ligands has been reported, as a nice possibility (vide infra), using for 
example, metal-binding combinatorial libraries for the discovery of new catalysts [117]. 
Chiral epoxy alcohols are also interesting building blocks for organic synthesis and 
consequently, asymmetric epoxidation of allylic alcohols has been largely developed. As a 
remarkable example, Katsuki and Sharpless reported in 1980, a highly enantioselective 
epoxidation of allylic alcohols using a titanium/tartrate/t-butyl hydroperoxide system [118]. 
Later, several other stereoselective systems were reported using chiral vanadium complexes 
as catalysts [119-122]. However, all these methods require the use of alkyl hydroperoxide as 
the oxidant. Asymmetric catalysis of epoxidation of allylic alcohols using hydrogen peroxide 
by niobium-salan complexes was recently discovered by the group of Katsuki [123, 124] 
(vide infra). 
Epoxidation catalyzed by non-heme iron and manganese complexes has been reviewed in 
2012 [125]. There are also several reviews on oxidation catalyzed by metalloporphyrins [4, 
126-128]. 
3.1 Iron systems 
3.1.1  non-heme systems   
Environmentally benign epoxidation protocols are an important challenge in organic 
chemistry and catalysis. In this regard, iron complexes are ideal catalysts owing to their 
availability, cost, and toxicity. Jacobsen et al. [129] have found Fe(II)(mep) (mep: N,N’-
dimethyl-N,N’-bis(2-pyridylmethyl)-ethane,1,2-diamine) with SbF6- counterions to be an 
efficient epoxidation catalyst with H2O2 in the presence of acetic acid (AcOH). A novel and 
general biomimetic non-heme Fe-catalyzed asymmetric epoxidation of aromatic alkenes by 
using hydrogen peroxide was reported by Beller and co-workers [130, 131]. The catalyst 
consists of ferric chloride hexahydrate (FeCl3,6H2O), pyridine-2,6-dicarboxylic acid, and 
readily accessible chiral N-arenesulfonyl-N’-benzyl-substituted ethylenediamine ligands 
(Scheme 7). The asymmetric epoxidation of styrene with this system gave high conversions 
but moderate enantiomeric excesses, whereas larger alkenes gave high conversions and ee 
values. 
Recently the enantioselective epoxidation of several alkenes, including terminal ones, 
has been realized by using new iron(III) complexes, generated in situ from primary amine-
derived non-symmetrical Schiff base ligands and aqueous H2O2 as environmentally benign 
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oxidant [33]. In case of trans-stilbene and derivatives, yields of up to 84% and ee values of up 
to 30% were obtained. Another system, using chiral bipyrrolidine based iron and manganese 
complexes [((S,S)-pdp)M(II)(OTf)2] (Scheme 8) catalyzes the asymmetric epoxidation of 
various olefins with H2O2 in the presence of carboxylic acid additives with high efficiency (up 
to 1000 turnover number (TON)) and selectivity (up to 100%), and with good to high 
enantioselectivity (up to 87% enantiomeric excess)(Scheme 8)[132]. The enantioselectivity 
increases with growing steric demand of the acid. On the basis of the electron paramagnetic 
resonance (EPR) spectroscopy and enantioselectivity studies, the active oxygen-transferring 
species of the above systems can be identified as structurally similar oxometal(V) species of 
the type [((S,S)-pdp)M(V)O(OCOR)]2+ (M = Fe, Mn; R = alkyl)[132]. 
Chiral bioinspired iron complexes of N4 ligands based on the ethylenediamine 
backbone (Figure 9) display remarkable levels of enantioselectivity for the first time in the 
asymmetric epoxidation of α,β-unsaturated ketones using hydrogen peroxide (up to 87% ee) 
as oxidant [133]. Notably, isotopic labeling with H218O strongly demonstrated that there is a 
reversible water binding step prior to generation of the significant intermediate. In addition, 
the possible mechanisms were proposed and LFe(V)=O species may be the main active 
intermediates in the catalytic system [133]. 
 
  3.1.2 Iron porphyrins
 
The discovery that hydrogen peroxide supports catalytic turnover of cytochrome P-450 
in the absence of electron transfer proteins or cosubstrates has been important for mechanistic 
studies of this enzyme [134]. In particular, it was proposed that P-450’s ability to utilize 
peroxides in place of dioxygen and NAD(P)H to drive hydroxylation via the peroxide shunt 
pathway could provide a way to confront the cofactor regeneration problem [135,136]. 
However, generally, the efficiency of this reaction is poor compared with that of reductive 
activation of molecular oxygen. It should be also noted that there are cytochromes P-450s, 
which can be classified as a H2O2-dependent P-450s[137,138]. Due to the obvious relevance 
of cytochrome P-450 mechanism, catalytic epoxidation by iron porphyrins has drawn 
particular attention [4,128,139]. Since the discovery of iron porphyrin catalyzed epoxidation 
and hydroxylation [140], the first asymmetric epoxidation catalyzed by chiral porphyrins was 
reported by Groves and Myers in 1983 [141]. Since then, different chiral iron porphyrins were 
used by the same group [42] and others [47,128,142-147]. The oxidant of choice for these 
systems is generally iodosylbenzene. Some examples of the use of hydrogen peroxide can be 
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found in the literature with iron porphyrins as catalysts [48, 50, 148, 149], but no reports of 
enantioselectivity [116]. It is only recently that chiral epoxidation of alkenes and 
hydroxylation of alkanes using H2O2 as oxidant has been successfully catalyzed by optically 
active water-soluble iron porphyrin (Figure 3) [150]. The asymmetric epoxidation of styrene 
derivatives by H2O2 (or UHP) to give optically active epoxides (ee up to 81%) was carried out 
in methanol and water using chiral water-soluble iron porphyrins as catalysts (Figure 3). 
 
3.2 Ruthenium catalysts 
 
The first asymmetric epoxidation catalyzed by a ruthenium complex (Scheme 9) that 
exploits hydrogen peroxide as the primary oxidant was reported in 1999 by Stoop and 
Mezzetti [151]. Up to 42% ee was obtained in the asymmetric epoxidation of styrene and 
other unfunctionalized olefins catalyzed by ruthenium Schiff based complex 
[RuCl(PNNP)]PF6 (PNNP = N,N-{bis(o-diphenylphosphino)benzylidene}-(1S,2S)-diimino-
cyclohexane using hydrogen peroxide as the primary oxidant [152]. 
A more general ruthenium catalyzed asymmetric epoxidation procedure of olefins 
using H2O2 has been developed by Beller and co-workers [153]. Using new pyboxazine type 
ligands (Scheme 10), enantioselectivies (generally 50-80%) up to 84% were observed for 
different aromatic olefins [153]. Using a different ruthenium complex, first introduced by 
Nishiyama and co-workers [154], the same group also succeeded asymmetric epoxidation 
with H2O2 but with less enantioselectivities (ee< 30%) [155]. 
A small ligand library of chiral tridentate N,N,N-pyridinebisimidazolines have been 
synthesized for the first time by Beller and co-workers (Scheme 11) [156]. This new class of 
ligands can be easily tuned and synthesized on multi g-scale. The usefulness of the ligands is 
shown in the ruthenium-catalyzed asymmetric epoxidation with hydrogen peroxide as 
oxidant. Excellent yields (>99%) and good enantioselectivities (up to 71% ee) have been 
obtained for the epoxidation of aromatic olefins [156]. 
 
3.3  Manganese systems 
 3.3.1  Non-porphyrinic manganese systems 
The groups of Jacobsen [157-159] and  Katsuki [160,161] pioneered the manganese-
salen-catalyzed enantioselective oxidation of unfunctionalized olefins. In these systems, 
oxygen transfer to the olefin is realized by C2-symmetric manganese(III)-salen type complex, 
using generally iodosoarenes or hypochlorite as terminal oxidants. However, hydrogen 
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peroxide was found to serve as an effective terminal oxidant for the salen-catalyzed 
asymmetric epoxidation of chromene derivatives (Scheme 12) [162] or 1,2-dihydronaphtalene
[163],  when N-methylimidazole was added to the reaction medium. Hydrogen peroxide has 
also been applied for a series of seven chiral pentadentate dihydrosalen ligands (Figure 10), 
carrying an imidazole group as a fifth, axial donor [164, 165]. These ligands were synthesized 
in racemic and enantiomerically pure form. All of these ligands afforded mononuclear 
manganese(III) complexes in good yields. The complexes catalyzed the epoxidation of olefins 
with a variety of terminal oxidants, but most importantly, with dilute (1%) aqueous hydrogen 
peroxide and without any added co-ligands. With 1,2dihydronaphthalene as substrate and 10 
mol% of catalyst, enantiomeric excesses up to 66% were achieved in 1996. This value was the 
highest at this time reported for an asymmetric epoxidation of 1,2-dihydronaphthalene, using 
hydrogen peroxide as oxidant and a salen-type complex as catalyst. 
 Chiral manganese complexes bearing optically active 1,4,7-triazacyclononanes were 
also able to catalyze the asymmetric oxidation of unfunctionalized olefins with hydrogen 
peroxide to give optically active epoxides with ees up to 43% but the conversion was quite 
low [166].  
Two dinuclear manganese complexes containing enantiomerically pure (R)- and (S)-1-
(2-hydroxypropyl)-4,7-dimethyl-1,4,7-triazacyclononane (S,S-1, R,R-1) ligands have been 
isolated as the hexafluorophosphate salts [167]. The enantiomeric complexes S,S-1 and R,R-1 
were found to catalyze the oxidation of olefins, alkanes, and alcohols with hydrogen peroxide. 
In the epoxidation of indene, the enantiomeric excess values attain 13%. 
A series of chiral tetradentate N4 ligands together with their manganese complexes 
have been designed and synthesized by Sun and coworkers (Scheme 13) [168]. Nice results 
were obtained with 1 mol % catalyst loading, since the enantioselective epoxidation of olefins 
proceeds with nearly full conversion and enantiomeric excess values up to 89%.  
The enantioselective epoxidation of 6-cyano-2,2-dimethylchromene (Chrom) 
catalyzed by the Jacobsen catalyst, using sodium hypochlorite (NaOCl) as oxygen source, at 
room temperature, was performed in a series of 1,3-dialkylimidazolium and tetra-alkyl-
dimethylguanidium based ionic liquids [169]. Other oxygen sources, such as iodosylbenzene, 
hydrogen peroxide and urea–hydrogen peroxide adduct, were also tested but the best results 
were achieved with NaOCl. 
Chiral non-heme aminopyridine manganese complexes (Figure 11) catalyze the 
enantioselective epoxidation of olefins with peracetic acid or hydrogen peroxide with 
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moderate to high yields and ee values up to 89% (peracetic acid, AcOOH) and 84%, 
performing as many as 1000 turnovers [170]. 
Chiral bipyrrolidine based iron manganese complexes [((S,S)-pdp)M(II)(OTf)2] 
catalyze the asymmetric epoxidation of various olefins with H2O2 in the presence of 
carboxylic acid additives with high efficiency (up to 1000 turnover number (TON)) and 
selectivity (up to 100%), and with good to high enantioselectivity (up to 93% enantiomeric 
excess. The enantioselectivity increases with growing steric demand of the acid (vide supra, 
Scheme 8) [132]. New ternary immobilization of chiral sulfonato-(salen)manganese(III) 
complex for aqueous asymmetric epoxidation reactions was also reported by Sun and 
coworkers [59]. 
Organic carbonates, e.g., dimethyl carbonate and propylene carbonate were used as 
reaction media in enantioselective epoxidation of non-functionalized alkenes by using a series 
of chiral macrocyclic Mn(III)salen complexes (5 mol%) as catalyst with pyridine N-oxide as 
oxidant [171]. This protocol worked effectively with urea hydrogen peroxide, as well as 
sodium hypochlorite as oxidants to give respective epoxides in high yields and ee (up to 
>91%) [171]. 
 
3.3.2 Manganese porphyrin  
A few examples of the use of hydrogen peroxide can be found in the literature with 
manganese porphyrins as catalysts (Figure 12) giving low enantiomeric excess for 
epoxidation reaction in organic solvents or in biphasic medium [172, 173], if we except one 
example for epoxidation of 1,2-dihydronaphtalene (ee up to 60%) [174]. It is only very 
recently that the asymmetric epoxidation of alkene derivatives by H2O2 to give optically 
active epoxides (ee up to 68%), was carried out in water/methanol solutions using a chiral 
water-soluble manganese porphyrin as catalyst [175]. Various factors affecting the catalytic 
epoxidation of olefins were extensively investigated. Thus, it was recognized that the 
presence of water in methanol can be quite successful. Moreover working in basic buffered 
solutions also deeply increases the efficiency of the system. Only a small excess of oxidant 
versus alkene was necessary for these reactions [175]. It has been also demonstrated that the 
benign H2O2/NaHCO3 oxidative combination can be used for the enantioselective epoxidation 
of olefins using a chiral manganese porphyrin as a catalyst [176]. This unprecedented result 
was made possible by the use of an ionic liquid with ultrasound, which leads to the activation 
of Mn-porphyrin catalysis but the enantioselectivity of the epoxidation was moderate 
(maximum ee: 40%) [176]. 
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3.3 Scandium catalysts 
 
A simple and H2O2-efficient asymmetric epoxidation of ,-unsaturated carbonyl 
compounds was accomplished using a chiral N,N-dioxide–Sc(III) complex catalyst [177]. A 
number of optically active epoxides were obtained from the corresponding ,-unsaturated 
ketones and ,-unsaturated amides under additive-free conditions. The catalytic system is 
convenient with good water- and air-tolerance, as well as excellent yields and 
enantioselectivities[177]. 
 
3.5  Niobium catalysts 
 
A dimeric µ-oxo Nb(salan) complex was found to catalyze the asymmetric 
epoxidation of  allylic alcohols using urea-hydrogen peroxide adduct as an oxidant with good 
enantioselectivity [123]. Subsequent studies indicated that the µ-oxo dissociates into a 
monomeric species prior to epoxidation [124]. These monomeric complexes catalyze the 
epoxidation of allylic alcohols using hydrogen peroxide with hig enantioselectivity ranging 
from 83 to 95% ee. This was reported as the first example of the highly enantioselective 
epoxidation of allylic alcohols using aqueous hydrogen peroxide as oxidant [124]. In some 
cases, the resulting epoxy alcohols were partially oxidized under the experimental conditions 
to the corresponding epoxy aldehydes (10-20%). 
 
3.6  Titanium catalysts 
 
In 1980, Katsuki and Sharpless reported the discovery of the first practical method for 
epoxidation [118]. It was the titanium-tartrate catalyzed asymmetric epoxidation of allylic 
alcohols by tert-butyl hydroperoxide. However, this stoichiometric oxidant generates a large 
amount of materials and a more highly atom-efficient is recommended and fortunately, 
oxidants other than tert-butyl hydroperoxide can also be used in the asymmetric epoxidation. 
Thus asymmetric epoxidation catalyzed by Ti(salalen) complexes (Scheme 14) [178, 179] and 
Ti(salan) (Scheme 15) [179-181] was developed by Katsuki group using aqueous hydrogen 
peroxide as the oxidant.In the presence of pH 7.4 phosphate buffer, the reaction of various 
conjugate olefins proceeded smoothly to afford the corresponding epoxides in high yield with 
high enantioselectivity. Bis--oxo-bridged binuclear Ti-salan catalysts have also been found 
A

to catalyze enantioselective epoxidation of olefins with H2O2 as the oxidant, demonstrating 
moderate to high enantioselectivities (55–98% ee values) [179, 180]. 
Titanium(salalen) complex was also an effective catalyst for asymmetric epoxidation 
of enol esters. Although (E)-enol esters were reluctant to proceed, (Z)-enol esters underwent 
asymmetric epoxidation to give the epoxides in high yields with high enantioselectivity 
ranging from 86 to >99% ee in the presence of aqueous hydrogen peroxide as the 
stoichiometric oxidant [182]. The obtained epoxides were transformed into the corresponding 
1,2-diols with no erosion of high enantiomeric excess. 
 
3.7  Platinumcatalysts 
 
[P2*Pt(CF3)(CH2C12)]BF3) (P2* = chiraphos, prophos, diop; X = C1, OH) cationic 
solvato complexes have been used as catalysts in the epoxidation of 1-octene and propene 
with diluted hydrogen peroxide (Scheme 16) [183]. The obtained epoxides are optically active 
with enantiomeric excess (ee) as high as 41%. Remarkable improvements in 
enantioselectivity as well as recycle were also observed in the catalytic asymmetric 
epoxidation of terminal alkenes with a chiral, electron-poor platinum(II) catalyst with 
hydrogen peroxide as terminal oxidant in water-surfactant media [184]. 
3.8 Copper catalysts 
Chiral copper proline diamide complex has been immobilized on surface of mesoporous 
silica [185]. These heterogenized complex catalysts were examined as asymmetric catalysts 
for the epoxidation of α,β-unsaturated carbonyl compounds with hydrogen peroxide, tert-
butyl hydroperoxide and urea hydroperoxide as the oxidants under solvent-free condition. 
Enantiomeric excesses of up to 84% can be achieved conveniently with a good conversion 
using these promising catalysts [185]. Interestingly, the recycled catalyst worked well up to 
five catalytic runs with marginal loss in yield. 
 
 3.9 Rhenium catalysts 
 
An impressive amount of work has been carried out on the catalytic properties of 
methyltrioxorhenium(VII) (MTO) and more specifically on its possibilities as a selective 
epoxidation catalyst using H2O2 as oxidant [186,187]. A review reported in 2005 described 
the different attempts to succeed enantioselective epoxidation catalyzed by rhenium and 
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molybdenum systems [188]. It was expected that the organometallic methyltrioxorhenium 
compound could be transformed into chiral epoxidation catalyst by adding chiral Lewis base 
ligands. One of the first attempts to utilize chiral N-base adducts of MTO as catalysts in chiral 
epoxidation was made by Corma et al. [189]. Unfortunately, the enantiomeric excess and the 
conversion were quite low (both inferior to 35%).  Methyltrioxorhenium(VII) (MTO) was 
also successfully applied as chiral epoxidation catalysts in the presence of H2O2 as oxidizing 
reagent and excess chiral Lewis base ligands derived from pyrazole [190]. These chiral Lewis 
base ligands allow to obtain moderate enantiomeric excesses (ee up to 41%), which are 
however, associated with generally low overall conversions (< 30%). Recently, several 
bidentate N-donor benzimidazolic adducts of MTO were synthesized and applied for catalytic 
olefin epoxidation using H2O2 as oxidant in CH2Cl2 at room temperature [191]. Since a major 
drawback of the rhenium system with hydrogen peroxide is the Lewis acidity of the catalyst in 
the presence of water, chiralbidentate N-donor benzimidazolic adducts may open new routes 
for asymmetric epoxidation. 
 
 In conclusion, the accomplishments achieved thus far in asymmetric catalytic epoxidation  
with hydrogen peroxide are impressive, but they are by no means complete. High 
enantiocontrol is characteristic of reactions with some alkene substrates but not styrene 
derivatives. A summary of selected asymmetric epoxidations so far showing the best 
enantioselectivity is given in the Table 2. Long-term catalyst stability vs hydrogen peroxide 
has not received adequate attention and new asymmetric catalysts are required. 
  
4. Asymmetric dihydroxylation of alkenes 
The development of the osmium catalyzed asymmetric cis-dihydroxylation of alkenes 
by Sharpless and co-workers [192,193] has proven to be invaluable to synthetic organic 
chemistry. However, the cost and toxicity of the osmium based asymmetric cis-
dihydroxylation system, prevents their widespread industrial application. This has provided a 
strong driving force to the identification and development of economically viable and 
environmentally benign methods based on first row transition metals and H2O2 [194, 195] . 
4.1 Iron catalysts 
The first example of iron-catalyzed asymmetric cis-dihydroxylation of olefins was 
reported in 2001 by Que and co-workers (ee up to 82%) [196]. The objective was to develop 
synthetic catalysts that model Rieske dioxygenases, which are bacterial enzymes, as a 
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potential green alternative to traditional heavy metal reagents such as OsO4 and RuO4 [193]. 
These compounds are effective but less desirable due to their toxicity. More recently, iron-
catalyzed asymmetric olefin cis-dihydroxylation has been recently reported with 97% 
enantiomeric excess [197]. The optically active ligands used in these reactions are shown in 
Figure 14. 
4.2  Manganese catalysts  
High turnover enantioselective alkene cis-dihydroxylation with H2O2 catalyzed by 
manganese based complexes containing chiral carboxylato ligands was reported for the first 
time by Feringa and co-workers [198,199]. With 0.4 mol% catalyst loading the 
enantioselective cis-dihydroxylation of 2,2-dimethylchromene (Scheme 17) proceeds with full 
conversion and high selectivity towards the cis-diol product with enantiomeric excess of up to 
54% and with high turnover. Selected homogeneous manganese catalytic systems, including 
‘ligand free’ and pyridyl amine ligand based systems, that have been applied to alkene 
dihydroxylation and epoxidation have been recently reviewed [200]. 
4.3 Osmium catalysts 
Although the Sharpless dihydroxylation of olefins with osmium tetraoxide has been used 
for several decades, osmium-catalyzed cis-dihydroxylation using H2O2 as oxidant is still rare. 
Selective cis-dihydroxylation of olefins with the aid of a triple catalytic system using H2O2 as 
the terminal oxidant has been developed [195]. In this process Os(VI) is recycled to Os(VIII) 
by a coupled electron transfer-mediator system based on N-methylmorpholine and a 
biomimetic flavin, leading to a mild and selective electron transfer. Aliphatic, aromatic, and 
functionalized olefins were successfully cis-dihydroxylated, employing the triple catalytic 
system. The present biomimetic catalytic system works well in asymmetric dihydroxylation 
and gave optically active diols in good isolated yields and high enantiomeric excesses (up to 
99% ee)[195]. A trifunctional catalyst for one-pot synthesis of chiral diols via Heck coupling-
N-oxidation-asymmetric dihydroxylation was also described by Choudary and co-workers 
[201]. The system was applied to the synthesis of diltiazem and taxol side chain. An improved 
process has been developed for the osmium-catalyzed dihydroxylation of olefins via in situ 
formation of N-methylmorpholine-N-oxide from N-methylmorpholine using CO2 catalysis 
and H2O2 [194]. All olefins examined were selectively cis-dihydroxylated to their 
corresponding diols in good to excellent yields, and by the use of chiral ligands, high 
enantiomeric excesses were obtained. A mechanism for the catalytic dihydroxylation of 
alkenes using hydrogen peroxide and osmium complexes has been recently proposed [202]. 
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5. Asymmetric hydroxylation of alkanes 
The functionalization of C-H bonds of alkanes is one of the most difficult transformation 
in synthetic chemistry [203-205]. Nevertheless, these reactions are catalyzed by a variety of 
metalloenzymes, among which the most diverse are the many members of the cytochrome P-
450 family [206]. Thus the extracellular heme-thiolate peroxygenase from Agrocybe aegerita 
has been shown to hydroxylate alkanes and numerous other substrates using hydrogen 
peroxide as the terminal oxidant [207, 208]. However the inert nature of non-activated C-H 
bonds generates large difficulties related to selectivity and enantioselectivity. Thus very few 
systems affording optically active alcohols using hydrogen peroxide as oxidant have been 
reported. This is true for non-heme systems and metalloporphyrin systems. They will be 
presented separately. 
5.1 Non-heme system 
Several bioinspired non-heme iron systems have been reported as attractive because 
they use hydrogen peroxide as oxidant. There is a recent review on this topic [125].  Thus 
various examples of alkane hydroxylations with hydrogen peroxide, catalyzed by non-heme 
iron complexes with polydentate N-donor ligands, have been reported since early 1990s but 
without any enantioselectivity. In contrast, the hydroxylation of alkanes by hydrogen peroxide 
catalyzed by a chiral µ-oxo diferric complex (Scheme 18) has been demonstrated by  
Fontecave et al. [209] to be stereospecific and partially enantioselective indicating a metal-
based mechanism. However, low enantiomeric excess was obtained with this system (up to 15 
%). 
5.2 Iron and manganese porphyrins  
Selective functionalization of saturated C–H bonds with metalloporphyrin catalysts 
has been reviewed recently by Che [204] and Zhang [205]. Among the metalloporphyrin-
catalyzed reactions highlighted herein are the hydroxylation of steroids, cycloalkanes and 
benzylic hydrocarbons. Since the discovery of iron porphyrin catalyzed hydroxylation [140], 
Groves and Viski [42, 210] reported the first enantioselective hydroxylation catalyzed by a 
metalloporphyrin, with up to 40% ee obtained from hydroxylation of ethylbenzene by PhIO 
using a chiral iron (III) porphyrin catalyst. When manganese was used as a metal, higher 
product yields were obtained, but with lower enantioselectivities. Ketones were also observed 
as side products in the catalytic reactions.  
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In 1999, Gross and Ini [211] reported the first example of ruthenium-catalyzed 
asymmetric hydroxylation of racemic alkanes and their kinetic resolution (ee up to 38%), 
using D2-symmetric chiral porphyrin ligand and 2,6-dichlropyridine N-oxide as oxidant. Che 
and coworkers [212,213] reported the Ru-catalyzed enantioselective hydroxylation of 
aromatic hydrocarbons with benzylic C–H bonds. Using 2,6-Cl2pyNO as oxidant, the chiral 
ruthenium porphyrin was shown to be an effective catalyst for hydroxylating a series of 
aromatic hydrocarbons to form the corresponding secondary alcohols. Although conversions 
of the substrates were low, the Ru-based hydroxylation gave good yields and up to 76% ee.  
The oxidant of choice for these systems is generally iodosylbenzene for iron and 
manganese catalysts, and dichloropyridine N-oxide with ruthenium catalysts. Some examples 
of the use of hydrogen peroxide for hydroxylation of saturated C-H bonds can be found in the 
literature with iron porphyrins as catalysts [48,148] but, only one example reports of 
enantioselectivity with iron catalysts [150]. Thus the asymmetric hydroxylation of alkanes to 
give optically active secondary alcohols (ee up to 63%) was carried out in methanol and water 
using a chiral water-soluble iron porphyrin as catalyst [150]. However, this reaction was 
limited to more reactive substrates such as indane and tetrahydronaphtalene.Other limitation 
is that the system needs an excess of alkene versus oxidant. Consequently, asymmetric 
hydroxylation of alkanes using hydrogen peroxide as oxidant is still difficult to proceed 
without electron-deficient chiral metalloporphyrins. 
A few examples of the use of H2O2 can be found in the literature with manganese 
porphyrins as catalysts, giving low enantiomeric excess (ee) for epoxidation reaction in 
organic solvents or in a biphasic medium[173,174]. However, to our knowledge, there were 
no examples of asymmetric hydroxylation by hydrogen peroxide in water catalyzed by Mn 
porphyrins until Simonneaux and co-workers [175] recently reported the asymmetric 
hydroxylation of arylalkane derivatives by H2O2 to give optically active alcohols (ee up to 
57%). The reactions were carried out in water/methanol solutions using chiral water-soluble 
manganese porphyrins as catalysts and five equiv of oxidant versus alkane was necessary. 
However, further optimization of the reaction medium to increase the enantioselectivity, and 
more experiments to identify the precise role of chirality in the mechanism will be necessary. 
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6. Conclusion 
Most of the work presented herein indicates that the asymmetric oxidation using chiral 
metal complexes as catalysts and hydrogen peroxide as oxidant is possible, with good results. 
Diastereo- and enantioselectivities comparable to those obtained with different oxidants are 
observed in organic solvents and in water. This is true for sulfoxidation reaction and in a less 
extent for epoxidation reaction. Although the number of efficient systems is relatively high, 
their development must be widened in the future for asymmetric hydroxylation of alkanes 
with hydrogen peroxide which remains an outstanding challenge in catalysis. The use of 
chiral heterogeneous catalysts [214] under ambient conditions offers several advantages 
compared to their homogeneous counterparts, such as ease of recovery and recycling and 
enhanced stability. With regard to oxidation catalysis in presence of hydrogen peroxide, the 
resistance to degradation merits further work since this factor is usually determinant on 
catalytic activity and selectivity. 
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Table 1. Selected catalytic asymmetric sulfoxidation of thioanisole with H2O2 
Catalyst Ee (%) Sulfoxide 
Yield (%) 
SO : SO2  Authors 

[Fe(acac)3]
OH
I
I
N
*
HO
+

 
 
 
90 
 
 
 
63 
 
 
 
91 : 9 
 
 
 
Bolm et al. 
[25] 
O O
N N
Fe
PhPh
(S)
(R)
Cl

 
 
 
96 
 
 
 
88 
 
 
 
91 : 9 
 
 
 
Katsuki et al.
[26] 


N
N N
N
SO3Na
NaO3S
SO3Na
SO3NaFe
Cl

 
 
 
 
 
 
85.5 
 
 
 
 
 
 
92 
 
 
 
 
 
 
92 : 8 
 
 
 
 
 
 
Simonneaux 
et al.[51] 
VO(acac)2
OH
I
N
HO
+

 
 
 
98 
 
 
 
62 
 
 
 
Nd 
 
 
 
Sun et al.
[78] 
O O
N N
Ti
H
2
H
OBr Br


 
 
 
46.7 
 
 
 
82 
 
 
 
82 : 18 
 
 
 
Bryliakov et 
al.[97] 


P
P
Pt
Ph
Ph
Ph
Ph
P
P
Pt
Ph
Ph
Ph
Ph
H
O
O
H
(BF4-)2



 
 
 
40 
 
 
 
98 
 
 
 
99 : 1 
 
 
 
Strukul et al.
[104] 
O O
N N
Al
PhPh
Cl

 
 
 
 
99 
 
 
 
 
78 
 
 
 
 
86 : 14 
 
 
 
 
Katsuki et al.
[108] 
SO = Sulfoxide, SO2 = Sulfone 
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Table 2: Selected asymmetric epoxidation catalyzed by metal complexes with H2O2 
Substrate Catalyst Ee 
(%) 
Authors 




P
P
Pt
OH2
F
F
F
F
F
CF3SO3-
+

 
 
 
 
84 
 
 
 
 
Colladon et 
al. [184]



 
 
99 



O O
N N
Ti
H
O
2

 
 
92 
 
 
 
 
 
Katsuki el al.
[181] 


 
 
44 
O
NC

 
63 
Br O




N N
N N
Mn
TfO OTf
t-Bu t-Bu

 
 
89 
 
 
 
 
 
Sun et al.
[168] 
	





O O
N N
Ti
H
O
2
H

 
 
 
 
 
98 
 
 
 
 
 
Katsuki el al.
[180] 
O

 
 
89 
O
NC

N
N
N
Mn
N
OTf
OTf

 
 
78 
 
 
 
 
Briliakov et 
al.[170] 




Cl 
N N
N
Cl OR
RO
Cl
OR
Cl
ClRO
Mn
Cl
R =
O
OAc
OAc
H
OAc
OAc

 
 
 
 
 
23 
 
 
 
 
 
Momenteau 
et al.[172] 



 
 
 
42 








N
N
N
R
R
N
N
R
R
R1R1
Ru
R1 = O Cl
O
N
O O
O O
R = Ph

 
 
 
68 
 
 
 
 
 
 
Beller et al. 
[156] 
A




 
 
 
62 



N
N N
N
SO3Na
NaO3S
SO3Na
SO3NaFe
Cl

 
 
80 
 
 
 
 
 
Simonneaux 
et al. [150] 



N
O
t-Bu
N
O
t-Bu
Mn
Cl
Ph Ph

 
 
 
60 
 
 
 
Pietikäinen 
et al. [163] 









N
N N
N
O
O
O
O
O
H
O
O
O
H
R
R=
O
O
Mn
Cl

 
 
 
 
 
 
 
68 
 
 
 
 
 
 
 
Collman et 
al.[174] 
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Figure 1. Structures of Sulindac (A) and Modafinil (B). 
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Figure 2. Selected ligands for asymmetric sulfoxidation from primary amine-derived non-
symmetrical Schiff bases [33]. 
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Figure 3. Halterman iron tetrasulfonated porphyrin [51] and Halterman manganese 
tetrasulfonated  porphyrin [175]. 
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Figure 4. Structures of the two enantiomers of ruthenium complexes [55]. 
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Figure 5. Structure of salen manganese complexes [56]. 
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Figure 6. Schiff base ligands used by Bolm and co-workers with VO(acac)2 (acac: 
acetylacetonate) [70]. 
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Figure 7. Structure of {[(R)-BINAP]Pt(m-OH)}2(BF4)2 complex for catalyzed asymmetric 
sulfoxidation of prochiral aryl alkyl sulfides with hydrogen peroxide in water with surfactants 
[104]. 
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Figure 8. Aluminium(salalen) complex as catalyst for asymmetric sulfoxidation in the 
presence of hydrogen peroxide [111]. 
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Figure 9. Chiral iron complexes for enantioselective epoxidation of α,β-unsaturated ketones 
[133]. 
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Figure 10. Chiral pentadentate dihydrosalen manganese complex for epoxidation of olefins 
[164] .  
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Figure 11. Chiral non-heme aminopyridine manganese complexes [170]. 
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Figure 12. Chiral manganese porphyrins bearing glycosyl groups [172]. 
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Figure 13. Niobium(salan) complexes [123]. 
	

N N
N N
* N N
N N
N N
N N
N N
N N
N N
N N
*
****
**
**
 
 
Figure 14.  Optically active ligands used after iron complexation for asymmetric cis-
dihydroxylation [197]. 
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Scheme 1. Oxidation of sulfide catalyzed by complex A or B [29]. 
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Scheme 2. Non-heme iron-catalyzed enantioselective sulfoxidation [24]. 
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Scheme 3. Asymmetric oxidation of sulfides with Fe(salan) [32]. 
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Scheme 4. Synthesis of ligands from a chiral cyclohexyl diamine backbone [57]. 
 
S
S
VO(acac)2, H2O2
chiral ligand
S
S
O
 
Scheme 5. Sulfoxidation of tert-butyl disulfide catalyzed by vanadium complexes [85]. 
 
B

H2O, Et3N
CH2Cl2 Ti O
O Ti N
O
O
N
O
N
N
O
MeOH
H2O2 Ti NN OO O
O
di-µ-oxo Ti(salen)
1
2
=
O O
N N
Ti
PhPh
(R)
(R)
Cl
S
MePh
1 (2 mol%), UHP (1 eq.)
MeOH, 0 °C
S+
MePh
O-
98% ee, 71%
Ti NN OO
Cl
Cl
Cl
Ti NN OO
Cl
Cl
 
 
Scheme 6. Asymmetric oxidation by Ti(salen) complex [94]. 
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Scheme 7. Asymmetric epoxidation catalyzed by iron and chiral ligands bearing sulfonyl 
group [130]. 
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Scheme 8. Chiral bipyrrolidine ligand based iron and manganes complexes [132]. 
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Scheme 9.  Asymmetric epoxidation catalyzed by chiral tetradentate Ru(II) complexes [152]. 
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Scheme 10. Ruthenium-pybox- catalyzed asymmetric epoxidation of styrene [153]. 
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Scheme 11. Synthesis of a Pybim library [156]. 
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Scheme 12. Enantioselective epoxidation of chromene catalyzed by Mn(salen) complex [162]. 
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Scheme 13. Asymmetric  epoxidation of olefins catalyzed by chiral tetradentate N4 
Manganese complexes [168]. 
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Scheme 14. Ti(salalen)-catalyzed asymmetric epoxidation [181].  
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Scheme 15. Asymmetric epoxidation of 1,2-dihydronaphtalene with Ti(salan) complex [181]. 
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Scheme 16. Asymmetric epoxidation of terminal alkenes with hydrogen peroxide catalyzed 
by chiral Pt complexes [184]. 
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Scheme 17. Asymmetric cis-dihydroxylation of chromene with H2O2 catalyzed by manganese 
complex [199]. 
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Scheme 18. Enantioselective hydroxylation of alkanes with H2O2 by non-heme iron complex 
[209]. 
 
 
 
 
 
